Acurx Pharmaceuticals, Inc. (ACXP)

NASDAQ: ACXP · IEX Real-Time Price · USD

3.83

-0.14 (-3.53%)

At close: Dec 29, 2023, 4:00 PM

3.90

+0.07 (1.83%)

After-hours: Dec 29, 2023, 7:13 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Selling, General & Admin	7.34	10.78	2.4	2.42
Research & Development	4.75	2.03	2.2	3.51
Operating Expenses	12.09	12.81	4.6	5.93
Operating Income	-12.09	-12.81	-4.6	-5.93
Other Expense / Income	-	-0.07	-	-
Pretax Income	-12.09	-12.75	-4.6	-5.93
Net Income	-12.09	-12.75	-4.6	-5.93
Shares Outstanding (Basic)	11	9	6	-
Shares Outstanding (Diluted)	11	9	6	-
Shares Change	26.72%	37.88%	-	-
EPS (Basic)	-1.12	-1.49	-0.74	-
EPS (Diluted)	-1.12	-1.49	-0.74	-
Free Cash Flow	-7.54	-5.01	-3.35	-3.99
Free Cash Flow Per Share	-0.70	-0.59	-0.54	-
EBITDA	-12.09	-12.75	-4.6	-5.93
EBIT	-12.09	-12.75	-4.6	-5.93

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).